Insider Scott Pittman Details $300K Loan to Nuo Therapeutics, Increasing Stake to 11.6%
AURX sits 26% above its 52-week low of $0.842 on light trading volume (0.1× avg).
Summary
Insider Scott M. Pittman has detailed his $300,000 contribution to Nuo Therapeutics' critical $2.0 million secured loan facility, increasing his beneficial ownership to 11.6% and signaling strong confidence amidst the company's financial distress.
Key Events · Ownership and Investor Activity · AURX
-
Insider Loan Contribution
Scott M. Pittman provided $300,000 in immediate funding to the company's $2.0 million secured loan facility, with a commitment for an additional $100,000.
-
Increased Beneficial Ownership
Pittman's beneficial ownership increased to 11.6% of common stock, including 47,500 shares from currently exercisable warrants.
-
Loan Terms
The loan bears 12% annual interest, payable in warrants, and is secured by all company assets, reflecting the company's urgent need for capital.
-
Warrant Issuance
Pittman received warrants exercisable at $1.50 per share as part of the loan agreement, providing potential future equity at a premium to the current stock price.
Analysis · AURX · Industrial Applications And Services
This filing details Scott M. Pittman's participation in the recently announced $2.0 million secured loan facility, providing $300,000 in immediate funding and committing to an additional $100,000. This insider capital infusion is critical for Nuo Therapeutics, which recently reported significant going concern doubts due to critically low cash. Pittman's increased beneficial ownership to 11.6% and his direct financial support signal strong insider confidence in the company's ability to navigate its financial challenges. The loan terms, including 12% interest and warrant issuances, reflect the company's urgent need for capital.
How filings like this one have moved
In the 30 days to Sep 30, 2026, 34.7% of the 1013 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.50%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AURX was trading at $1.06 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $51.3M. The 52-week trading range was $0.84 to $3.23. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.